Source: BUSINESS WIRE

Press Release: SuppreMol : Baxter's BioScience Business Acquires Biopharmaceutical Company SuppreMol

DEERFIELD, Ill. & MUNICH--(BUSINESS WIRE)--Baxter has acquired German biopharmaceutical company SuppreMol GmbH for EUR 200 million before working capital and other adjustments.

Read full article »
SuppreMol's Competitors | SuppreMol's News | SuppreMol's Financials
Stay up-to-date with the latest news on SuppreMol
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Klaus Schollmeie's photo - CEO of SuppreMol

CEO

Klaus Schollmeie

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on SuppreMol